NYSE ARCA | ETF
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index.
The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business.
GLP-1 agonists seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss.
The fund is non-diversified.
Top 15 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 14.90% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 14.78% |
| NVO | Novo Nordisk A/S | Healthcare | Biotechnology | 12.82% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 7.38% |
| 4519 | Chugai Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - General | 6.56% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 5.90% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 5.60% |
| 4901 | Fujifilm Holdings Corp. | Industrials | Conglomerates | 5.31% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.12% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.02% |
| WST | West Pharmaceutical Services Inc | Healthcare | Medical Instruments & Supplies | 4.98% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 4.91% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.79% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.78% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.75% |